Sarda Proteins

Is Sarda Proteins overvalued or undervalued?

As of January 6, 2025, Sarda Proteins Ltd. is considered overvalued with a "risky" rating due to high financial ratios, including a PE Ratio of 22.60 and a Price to Book Value of 9.54, despite a strong 1-year return of 62.51%.

As of 6 January 2025, Sarda Proteins Ltd. has moved from a grade of "does not qualify" to "risky," indicating a shift in its valuation outlook. The company appears to be overvalued based on its current financial ratios. The PE Ratio stands at 22.60, while the Price to Book Value is significantly high at 9.54, and the EV to Sales ratio is 21.29, all suggesting that the stock price may not be justified by its earnings or asset value.<BR><BR>In comparison to its peers, Sarda Proteins' PE ratio is higher than the industry average, which raises concerns about its valuation. Notably, its EV to EBITDA is -22.57, indicating negative earnings before interest, taxes, depreciation, and amortization, which is a significant red flag. While the company has outperformed the Sensex with a 1-year return of 62.51% compared to the Sensex's 7.57%, this performance may not be sustainable given the current valuation metrics. Overall, Sarda Proteins appears to be overvalued in the current market environment.

What is the technical trend for Sarda Proteins?

As of May 20, 2025, Sarda Proteins shows a mildly bullish trend with mixed signals from indicators like the MACD, Bollinger Bands, and RSI, suggesting caution despite the current price being at a 52-week high of 137.45.

As of 20 May 2025, the technical trend for Sarda Proteins has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the monthly RSI shows bearish momentum. Daily moving averages remain bullish, supporting the current price of 137.45, which is at a 52-week high. The KST is mildly bearish on a weekly basis but bullish monthly, and Dow Theory reflects a mildly bullish outlook in both time frames. Overall, the strength of the bullish trend is tempered by mixed signals in the RSI and KST, suggesting caution despite the positive indicators.

How has been the historical performance of Sarda Proteins?

Sarda Proteins has shown significant sales growth, with net sales rising from 1.30 Cr in Mar'24 to 24.19 Cr in Mar'25, but faced challenges with increased expenditures, resulting in marginal operating profit and a decrease in profit after tax and EPS. Overall, while sales and total assets have grown, profitability remains a concern.

Answer:<BR>The historical performance of Sarda Proteins shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Sarda Proteins experienced a notable increase in net sales, rising from 1.30 Cr in Mar'24 to 24.19 Cr in Mar'25, following a trend of varying sales figures over the previous years. The total operating income also reflected this growth, reaching 24.19 Cr in Mar'25 compared to 1.30 Cr in the prior year. However, the company faced challenges with total expenditure, which increased to 24.17 Cr in Mar'25 from 1.44 Cr in Mar'24. This resulted in a marginal operating profit of 0.02 Cr in Mar'25, a slight improvement from the losses recorded in earlier years. The profit before tax remained stable at 0.02 Cr for both Mar'25 and Mar'24, while profit after tax showed a decrease to 0.01 Cr in Mar'25 from 0.02 Cr in Mar'24. The earnings per share (EPS) also reflected this trend, decreasing to 0.06 in Mar'25 from 0.12 in Mar'24. On the balance sheet, total assets increased to 2.53 Cr in Mar'25 from 2.30 Cr in Mar'24, driven by a rise in short-term loans and advances. Overall, while Sarda Proteins has shown growth in sales and total assets, profitability metrics indicate ongoing challenges.

When is the next results date for Sarda Proteins Ltd?

The next results date for Sarda Proteins Ltd is 14 February 2026.

The next results date for Sarda Proteins Ltd is scheduled for 14 February 2026.

Should I buy, sell or hold Sarda Proteins Ltd?

Why is Sarda Proteins Ltd falling/rising?

As of 26-Mar, Sarda Proteins Ltd's stock price is stable at Rs 84.48, with a recent 15.74% increase over the past week. However, concerns about the company's long-term financial health, including operating losses and declining net sales, suggest potential risks for future stability.

As of 26-Mar, Sarda Proteins Ltd's stock price is currently stable at Rs 84.48, showing no change (0.00%). However, the stock has exhibited a significant upward trend over the past week, with a remarkable increase of 15.74%, and a 24.24% rise over the past month. This performance is particularly noteworthy as it has outperformed the benchmark Sensex, which has declined by 1.87% in the same week and 8.51% over the month.<BR><BR>Today's trading session has seen the stock open with a gain of 5%, reaching an intraday high of Rs 84.48. The stock has been on a consecutive gain streak for the last five days, contributing to a total return of 24.25% during this period. Additionally, Sarda Proteins is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive short-term trend.<BR><BR>Despite these positive indicators, there are underlying concerns regarding the company's long-term fundamentals. The company is facing operating losses and has a weak ability to service its debt, as evidenced by a poor EBIT to Interest ratio of -0.02. Furthermore, the company has reported a significant decline in net sales, down 36.08% over the last nine months, and has a negative EBITDA, which suggests that the stock is considered risky compared to its historical valuations.<BR><BR>In summary, while Sarda Proteins Ltd is currently experiencing a rise in stock price due to recent performance and market trends, the company's long-term financial health raises concerns that could impact future stability.

Why is Sarda Proteins Ltd falling/rising?

As of 27-Mar, Sarda Proteins Ltd's stock price is stable at Rs 84.48, with a recent 5.00% increase over the past week and a 24.24% rise over the month. However, the company faces significant financial challenges, including operating losses and declining net sales, raising concerns about its long-term viability.

As of 27-Mar, Sarda Proteins Ltd's stock price is currently stable at Rs 84.48, showing no change (0.00%). However, the stock has demonstrated a notable upward trend over the past week, with a rise of 5.00%, and a significant increase of 24.24% over the past month. This performance is particularly impressive when compared to the Sensex, which has declined by 1.27% in the last week and 9.48% in the last month.<BR><BR>Today's trading activity indicates that Sarda Proteins has outperformed its sector by 10.01%, and it opened with a gain of 5%, reaching an intraday high of Rs 84.48. The stock has been gaining for the last five days, reflecting a positive momentum with a total return of 24.25% during this period. Furthermore, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong short-term performance.<BR><BR>Despite these positive indicators, there are underlying concerns regarding the company's financial health. Sarda Proteins has reported operating losses and has a weak long-term fundamental strength, as evidenced by a poor EBIT to Interest ratio of -0.02 and a low return on equity of 3.91%. Additionally, the company has faced a significant decline in net sales, which fell by 36.08% over the past nine months, and its earnings per share reached a low of Rs -7.06.<BR><BR>Overall, while the stock is currently experiencing a rise in price due to recent performance and market activity, the company's financial challenges and negative EBITDA position raise concerns about its long-term viability.

Why is Sarda Proteins Ltd falling/rising?

As of 28-Mar, Sarda Proteins Ltd's stock price is stable at Rs 84.48, having gained 5.00% over the past week and 24.24% over the past month. However, the company's long-term fundamentals are concerning, with operating losses and a significant decline in net sales, indicating potential risks for investors.

As of 28-Mar, Sarda Proteins Ltd is experiencing a stable stock price at Rs 84.48, with no change recorded for the day. However, the stock has shown a notable upward trend over the past week, gaining 5.00%, and has risen significantly by 24.24% over the past month. This performance is particularly impressive when compared to the Sensex, which has declined by 1.27% in the same week and by 9.48% over the past month.<BR><BR>Today's trading activity indicates that the stock opened with a gain of 5% and reached an intraday high of Rs 84.48, reflecting strong market interest. The stock has been on a consecutive gain streak for the last five days, contributing to a total increase of 24.25% during this period. Furthermore, Sarda Proteins is trading above its moving averages across various time frames, indicating a positive momentum.<BR><BR>Despite these short-term gains, there are underlying concerns regarding the company's long-term fundamentals. The company has reported operating losses and a weak ability to service its debt, with a poor EBIT to Interest ratio of -0.02. Additionally, the net sales have decreased by 36.08% over the last nine months, and the earnings per share have reached a low of Rs -7.06. These factors suggest that while the stock may be rising in the short term, the overall financial health of Sarda Proteins Ltd remains weak, which could pose risks for investors in the long run.

Why is Sarda Proteins Ltd falling/rising?

As of 29-Mar, Sarda Proteins Ltd's stock price is stable at Rs 84.48, with a recent 5.00% increase over the past week and a 24.24% rise over the past month. However, the company faces long-term challenges, including operating losses and a significant decline in net sales, which could affect its future performance.

As of 29-Mar, Sarda Proteins Ltd's stock price is currently stable at Rs 84.48, showing no change (0.00%). However, the stock has demonstrated a notable upward trend over the past week, with a 5.00% increase, and a significant 24.24% rise over the past month. This performance is particularly impressive when compared to the Sensex, which has declined by 1.27% over the past week and 9.48% over the past month.<BR><BR>Today's trading activity indicates that the stock opened with a gain of 5% and has maintained this price throughout the day, reaching an intraday high of Rs 84.48. The stock has been on a consecutive gain streak for the last five days, contributing to a total return of 24.25% during this period. Additionally, Sarda Proteins is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive momentum.<BR><BR>Despite these short-term gains, there are underlying concerns about the company's long-term fundamentals. Sarda Proteins has reported operating losses and a weak ability to service its debt, with a poor EBIT to Interest ratio of -0.02. The company's net sales have decreased significantly by 36.08% over the past nine months, and it has recorded a negative earnings per share of Rs -7.06 for the latest quarter. Furthermore, the stock has underperformed the market over the past year, with a return of -32.28% compared to the BSE500's -2.30%.<BR><BR>In summary, while Sarda Proteins Ltd is experiencing a rise in stock price in the short term, driven by recent gains and positive trading activity, the company faces significant long-term challenges that could impact its future performance.

Which are the latest news on Sarda Proteins?

Which are the latest news on Sarda Proteins?

Which are the latest news on Sarda Proteins?